Cargando…
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
The recent outbreak of Coronavirus disease (COVID-19), first in Eastern Asia and then essentially across the world has been declared a pandemic by the WHO. COVID-19 is caused by a novel virus SARS-CoV2 (2019-nCoV), against which there is currently no vaccine available; and current antiviral therapie...
Autores principales: | Parvathaneni, Vineela, Gupta, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430345/ https://www.ncbi.nlm.nih.gov/pubmed/32818545 http://dx.doi.org/10.1016/j.lfs.2020.118275 |
Ejemplares similares
-
Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action
por: Parvathaneni, Vineela, et al.
Publicado: (2022) -
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
por: Kulkarni, Nishant S., et al.
Publicado: (2020) -
Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment
por: Parvathaneni, Vineela, et al.
Publicado: (2023) -
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
por: Parvathaneni, Vineela, et al.
Publicado: (2021) -
Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)